Employers are predicting an increase of as much as 9 percent, on average, but are generally avoiding passing along much of that to their employees, industry groups say.
Related Posts
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Trump’s Perfume Line Hits the Market With Jill Biden Photo
Everything around President-elect Donald J. Trump has become something to monetize, including a moment of comity with Jill Biden at Notre-Dame over the weekend.
Musk, Trump, A.I. and Other DealBook Summit Highlights
The economy, inflation, tariffs, the future of media, pardon politics and other big topics that made headlines this year.